Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 25;11(11):399.
doi: 10.21037/atm-23-314. Epub 2023 Feb 27.

Treatment of endocrine resistant metastatic breast cancer in the era of antibody drug conjugates

Natalie K Heater  1 , Stephanie Franco  1 , Ami Shah  2
Affiliations
Editorial

Treatment of endocrine resistant metastatic breast cancer in the era of antibody drug conjugates

Natalie K Heater et al. Ann Transl Med. .
No abstract available

Keywords: Breast cancer; antibody drug conjugates; hormone-receptor positive (HR+); sacituzumab govitecan (SG); trastuzumab deruxtecan (T-DXd).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-23-314/coif). AS reports participation in an advisory board from AstraZeneca and Gilead and payment for this service. The other authors have no conflicts of interest to declare.

Comment on

References

    1. Rugo HS, Bardia A, Marmé F, et al. Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer. J Clin Oncol 2022;40:3365-76. 10.1200/JCO.22.01002 - DOI - PubMed
    1. Modi S, Jacot W, Yamashita T, et al. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer. N Engl J Med 2022;387:9-20. 10.1056/NEJMoa2203690 - DOI - PMC - PubMed
    1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209-49. 10.3322/caac.21660 - DOI - PubMed
    1. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7-33. 10.3322/caac.21708 - DOI - PubMed
    1. Gradishar WJ, Moran MS, Abraham J, et al. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2022;20:691-722. 10.6004/jnccn.2022.0030 - DOI - PubMed